Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2026-02-25 00:00:00 ET · period of report 2026-02-23 · accession 0001193125-26-072481 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-25 | 2026-02-23 | AXSM | Coleman Mark | Dir | M - OptEx | $4.95 | +6,250 | 72.1K | +9% | +$30.9K |
| D | 2026-02-25 | 2026-02-23 | AXSM | Coleman Mark | Dir | M - OptEx | $0.00 | -6,250 | 7,721 | -45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-23 | M | A | 6,250 | $4.95 | 72,140 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-02-23 | M | D | 6,250 | $0.00 | 7,721 | D | $4.95 · 2018-03-15 to 2027-03-15 | 6,250 Common Stock |